Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia-Reference-Cited by-同舟云学术

Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia

Published:2014-06-15 Issue:06 Volume:75 Page:608-615
ISSN:0160-6689
Container-title:The Journal of Clinical Psychiatry
language:
Short-container-title:J. Clin. Psychiatry

Author:

Usall Judith,López-Carrilero Raquel,Iniesta Raquel,Roca Mercedes,Caballero Montserrat,Rodriguez-Jimenez Roberto,Oliveira Cristina,Bernardo Miguel,Corripio Iluminada,Sindreu Santiago Durán,Piqueras Jose Carlos González,Felipe Ana Espliego,de Corres Blanca Fernandez,Ibáñez Angela,Huerta Raúl,

Publisher

Physicians Postgraduate Press, Inc

Subject

Psychiatry and Mental health

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-generation genome sequencing implicates medium-sized structural variants in chronic schizophrenia;Frontiers in Neuroscience;2023-01-11

2. Meta-analysis on the efficacy of the norepinephrine reuptake inhibitors reboxetine and atomoxetine for the treatment of schizophrenia and attention deficit hyperactivity disorder;Advances in Clinical and Experimental Medicine;2022-11-30

3. Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia;Personalized Psychiatry and Neurology;2021-11-14

4. Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review);Experimental and Therapeutic Medicine;2021-01-25

5. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials;Pharmacopsychiatry;2019-06-17